Oncology Information Systems Market Share, and Forecast 2025-2033

Market Overview:

The oncology information systems market is experiencing rapid growth, driven by growing adoption of cloud-based solutions, rising demand for personalized treatment, and regulatory compliance & data security challenges. According to IMARC Group's latest research publication, "Oncology Information Systems Market Report by Product and Services (Software, Services), Application (Radiation Oncology, Medical Oncology, Surgical Oncology), End User (Hospitals and Diagnostic Imaging Centers, Ablation Care Centers and Cancer Care Centers, Government Institutions, Research Facilities), and Region 2025-2033", The global oncology information systems market size reached USD 4.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.95% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Grab a sample PDF of this report: https://www.imarcgroup.com/oncology-information-systems-market/requestsample

Our report includes:

• Market Dynamics
• Market Trends And Market Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Growth Factors in the Oncology Information Systems Market

• Rising Prevalence of Cancer Worldwide:

The increasing number of cancer cases globally is a significant driver for the Oncology Information Systems (OIS) market. As cancer incidence rises, healthcare providers face the challenge of managing vast amounts of patient data, including medical histories, treatment plans, and outcomes. OIS solutions streamline this process by offering centralized platforms to store and analyze data, improving efficiency and patient care. For example, hospitals in the U.S., like the Mayo Clinic, have adopted OIS to manage the growing volume of oncology patients, enabling better coordination between oncologists, radiologists, and surgeons. This demand for efficient data management systems continues to fuel market expansion as cancer remains a leading health concern.

• Advancements in Healthcare IT Infrastructure:

Technological improvements in healthcare IT are propelling the OIS market forward. Modern OIS platforms integrate with electronic health records (EHRs), medical imaging systems, and laboratory databases, creating seamless workflows for oncology care. These advancements allow for real-time data sharing and enhanced decision-making. For instance, Varian Medical Systems has developed OIS solutions that connect with radiotherapy equipment, enabling precise treatment planning. Governments, particularly in North America and Europe, are investing heavily in healthcare IT to support digital transformation, further driving OIS adoption. This focus on interoperability and data-driven care ensures that OIS remains a critical tool in modern oncology practices.

• Government Initiatives and Funding:

Government support through funding and policy initiatives is a key growth factor for the OIS market. Many countries are allocating resources to improve cancer care infrastructure, including the adoption of advanced IT systems. For example, the U.S. government’s Cancer Moonshot initiative has encouraged the integration of OIS in hospitals to enhance research and treatment outcomes. Similarly, in Europe, programs like the National Cancer Research Institute promote data sharing through OIS platforms to advance oncology studies. These initiatives not only provide financial backing but also create a regulatory environment that encourages healthcare facilities to invest in OIS, boosting market growth.

Key Trends in the Oncology Information Systems Market

• Integration of Artificial Intelligence in OIS:

The incorporation of artificial intelligence (AI) into OIS is transforming oncology care by improving diagnostic accuracy and treatment planning. AI-powered OIS can analyze large datasets to identify patterns, predict patient outcomes, and recommend personalized therapies. For example, Flatiron Health’s OIS uses AI to extract insights from unstructured clinical data, helping oncologists make informed decisions. This trend is gaining traction as healthcare providers seek to reduce human error and enhance efficiency. Companies like Elekta are also embedding AI in their OIS platforms to optimize radiation therapy, making AI a pivotal trend shaping the future of the market.

• Adoption of Telemedicine and Remote Monitoring:

The rise of telemedicine and remote patient monitoring is a significant trend in the OIS market, accelerated by the COVID-19 pandemic. OIS platforms now support virtual consultations, remote tumor boards, and real-time patient tracking, allowing care delivery beyond traditional settings. For instance, Cerner Corporation’s OIS enables oncologists to monitor patient progress remotely, improving access for patients in rural areas. This trend enhances patient convenience and reduces hospital readmissions by enabling early intervention. As telemedicine becomes a standard in oncology, OIS vendors are prioritizing features that support remote care, driving innovation and market growth.

• Focus on Interoperable and Patient-Centric Systems:

Interoperability and patient-centric design are emerging as critical trends in the OIS market. Healthcare providers demand OIS platforms that seamlessly integrate with existing systems, such as EHRs and imaging tools, to ensure smooth data flow. Additionally, there’s a shift toward systems that prioritize patient engagement, offering portals for patients to access treatment plans and communicate with providers. For example, Epic Systems’ OIS includes patient portals that enhance transparency and involvement in care. This trend aligns with the broader move toward value-based care, where interoperability and patient satisfaction are key, encouraging OIS developers to create more connected and user-friendly solutions.

Leading Companies Operating in the Global Oncology Information Systems Industry:

• Accuray Incorporated
• Advanced Data Systems
• Cerner Corporation (Oracle Corporation)
• CureMD Healthcare
• Elekta
• EndoSoft LLC (Utech Products Inc.)
• F. Hoffmann-La Roche Ltd
• Koninklijke Philips N.V.
• McKesson Corporation
• OPTUM Inc. (United Healthcare Services Inc.)
• RaySearch Laboratories
• Varian Medical Systems Inc.

Oncology Information Systems Market Report Segmentation:

By Product and Services:

• Software
• Patient Information Systems
• Treatment Planning Systems
• Services
• Consulting Services
• Implementation Services
• Maintenance Services

Software (patient information systems and treatment planning systems) represents the largest segment as it streamlines workflows by digitizing patient records, making information readily accessible to healthcare providers.

By Application:

• Radiation Oncology
• Medical Oncology
• Surgical Oncology

Medical oncology represents the leading segment due to its capability to centralize patient data, including medical history, diagnostic tests, imaging results, treatment plans, and follow-up care.

By End User:

• Hospitals and Diagnostic Imaging Centers
• Ablation Care Centers and Cancer Care Centers
• Government Institutions
• Research Facilities

Hospitals and diagnostic imaging centers account for the majority of the market share owing to the rising number of cancer patients seeking effective treatment.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America's dominance in the oncology information systems market is attributed to the rising prevalence of cancer among the masses due to adoption of unhealthy lifestyle habits and smoking.

Research Methodology:

The report employs a comprehensive research methodology, combining primary and secondary data sources to validate findings. It includes market assessments, surveys, expert opinions, and data triangulation techniques to ensure accuracy and reliability.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145